Aortic Stenosis Clinical Trial
— IMPACT SDMOfficial title:
PCORI-CDR-2022C1-26333 Promoting Shared Decision Making for Decisions About Treatment of Severe Aortic Stenosis (IMPACT SDM Study)
The goal of this study is to increase shared decision making for patients considering treatment for severe aortic stenosis. The main questions it aims to answer are: - Do patient decision aids and clinician skills training course improve the quality of decisions, and do they work well for different patient populations? - Are heart clinics able to reach the majority of patients with decision aids before their specialist visit and do the majority of clinicians complete the training course? All participating sites will start in the usual care group and then will be randomly assigned a time to switch to the intervention group. Participants will complete surveys before and after their specialist visit. Researchers will compare data from patients seen during usual care with data from those seen after the interventions are implemented to see if there are improvements in the quality of decisions.
Status | Not yet recruiting |
Enrollment | 1400 |
Est. completion date | October 31, 2027 |
Est. primary completion date | May 31, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years to 85 Years |
Eligibility | Inclusion Criteria: - Between 65-85 years of age - Language is English or Spanish - Diagnosed with severe aortic stenosis (aortic valve area <1cm2) - Attend Visit with Heart Valve Team physician(s) Exclusion Criteria: - Prior aortic valve replacement surgery - High surgical risk (determined by clinician or defined as Society of Thoracic Surgery score >8%) - Prior coronary artery bypass surgery (CABG) - End stage renal disease on dialysis - Severe lung disease (chronic obstructive pulmonary disease; COPD) requiring home oxygen - Advanced Cirrhosis - Unable to consent for self (proxy respondents are not allowed) |
Country | Name | City | State |
---|---|---|---|
United States | Emory University | Atlanta | Georgia |
United States | Piedmont Healthcare | Atlanta | Georgia |
United States | University of Colorado Denver | Aurora | Colorado |
United States | Massachusetts General Hospital | Boston | Massachusetts |
United States | The University of North Carolina at Chapel Hill | Chapel Hill | North Carolina |
United States | UT Southwestern Medical Center | Dallas | Texas |
United States | Providence Health & Services - Oregon | Portland | Oregon |
United States | The Regents of the University of California, San Francisco | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital | Emory University, Patient-Centered Outcomes Research Institute, Piedmont Healthcare, Providence Health & Services, University of California, San Francisco, University of Colorado, Denver, University of North Carolina, Chapel Hill, University of Texas |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Shared Decision Making | Shared Decision Making Process scale; Scores range 0-4 with higher scores indicating greater shared decision making occurred. | About 1 week post visit | |
Secondary | Reach | % of eligible patients who receive decision aid | About 1 week post visit | |
Secondary | Patient Knowledge | Multiple choice knowledge score ranging from 0-100; higher scores indicate higher knowledge | About 1 week post visit | |
Secondary | Preference-treatment concordance | % of patients who received preferred treatment within 6 months of visit | About 1 week post visit | |
Secondary | Patient experience | CAHPS MD-patient communication subscale and visit rating score | About 1 week post visit | |
Secondary | Clinician satisfaction | % of clinicians who mark "very" or "extremely" satisfied with visit | About 1 week post visit | |
Secondary | Adoption | % of eligible clinicians who complete the shared decision making skills training | 4 weeks from the start of intervention period for each site | |
Secondary | Timeliness (time to decision) | % of patients who report stage of decision making is "made a decision" | About 1 week post visit | |
Secondary | Timeliness (burden) | % of visits where clinicians report visit length is "longer than normal" | About 1 week post visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04310046 -
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
|
N/A | |
Completed |
NCT03332745 -
Mechanism of Decompensation Evaluation - Aortic Stenosis
|
||
Recruiting |
NCT06008080 -
Post-Market Clinical Follow Up Study With Navitor Valve
|
||
Recruiting |
NCT06055751 -
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
|
||
Active, not recruiting |
NCT04815785 -
Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
|
N/A | |
Terminated |
NCT02202434 -
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
|
N/A | |
Recruiting |
NCT03029026 -
The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
|
||
Active, not recruiting |
NCT02903420 -
A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
|
N/A | |
Completed |
NCT02629328 -
CardioCel Tri-leaflet Repair Study
|
N/A | |
Completed |
NCT02306226 -
Symetis ACURATE Neo™ Valve Implantation SAVI TF Registry
|
||
Withdrawn |
NCT01648309 -
Neuropsychological Testing in Patients Undergoing Transvascular Aortic Valve Implantation
|
N/A | |
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Completed |
NCT01422044 -
Risk Prediction in Aortic Stenosis
|
N/A | |
Withdrawn |
NCT00774657 -
Ventricular Remodeling In Patients With Aortic Stenosis Assessed Echocardiography
|
N/A | |
Terminated |
NCT00535899 -
Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)
|
N/A | |
Terminated |
NCT05070130 -
OpSens PRIME CLASS
|
||
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Completed |
NCT04157920 -
Impact of Predilatation Between Self-expanding Valves
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT05893082 -
Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
|
N/A |